Kohei Yamauchi Selected Research

Protein D-Aspartate-L-Isoaspartate Methyltransferase (Protein L Isoaspartate D Aspartate O Methyltransferase)

3/2018	Deficiency of protein-L-isoaspartate (D-aspartate) O-methyl-transferase expression under endoplasmic reticulum stress promotes epithelial mesenchymal transition in lung adenocarcinoma.
4/2016	Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kohei Yamauchi Research Topics

Disease

21	Asthma (Bronchial Asthma) 01/2022 - 04/2002
11	Inflammation (Inflammations) 01/2022 - 06/2006
6	Hypersensitivity (Allergy) 04/2019 - 03/2008
5	Neoplasms (Cancer) 11/2019 - 10/2002
4	Idiopathic Pulmonary Fibrosis 01/2021 - 04/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 04/2017 - 09/2013
4	Vasculitis (Vasculitides) 04/2016 - 05/2010
4	Airway Remodeling 09/2013 - 06/2006
3	Respiratory Hypersensitivity 01/2022 - 09/2013
3	Adenocarcinoma of Lung 11/2019 - 04/2016
3	Lung Neoplasms (Lung Cancer) 09/2017 - 01/2016
3	Hyperplasia 02/2011 - 03/2008
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 01/2018
2	Pneumonia (Pneumonitis) 12/2016 - 06/2009
2	Vascular Remodeling 04/2016 - 09/2014
2	Emphysema 01/2016 - 09/2013
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2014 - 08/2013
2	Endotoxemia 02/2014 - 05/2006
2	Cough 11/2013 - 08/2002
2	Obstructive Sleep Apnea 03/2005 - 07/2004
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Acute Lung Injury 01/2022
1	Lung Injury 01/2022
1	Airway Obstruction (Choking) 04/2019
1	Edema (Dropsy) 04/2019
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2019
1	Sarcoidosis (Schaumann Disease) 01/2019
1	Hypoxia (Hypoxemia) 03/2018
1	Cryptogenic Organizing Pneumonia 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017
1	Rhinosinusitis 04/2017
1	Otitis 04/2017
1	Allergic Rhinitis 04/2017
1	Aspirin-Induced Asthma 04/2017
1	Neoplasm Metastasis (Metastasis) 05/2016
1	Colorectal Neoplasms (Colorectal Cancer) 05/2016

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2006
6	Histamine (Histamine Dihydrochloride)FDA Link 04/2019 - 05/2006
6	Immunoglobulin E (IgE)IBA 04/2019 - 09/2011
6	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2018 - 06/2006
5	CytokinesIBA 04/2019 - 06/2006
5	Theophylline (Theon)FDA LinkGeneric 04/2017 - 04/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2013
4	AntibodiesIBA 01/2022 - 04/2016
4	Vascular Endothelial Growth Factor CIBA 01/2022 - 04/2013
4	Pharmaceutical PreparationsIBA 09/2017 - 06/2009
4	Aminophylline (Carine)FDA LinkGeneric 04/2017 - 04/2002
3	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2010
3	Interleukin-13IBA 01/2019 - 09/2011
3	Interleukin-5 (Interleukin 5)IBA 01/2019 - 05/2010
3	ParaffinIBA 01/2018 - 04/2016
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 04/2017 - 01/2014
3	Epinephrine (Adrenaline)FDA LinkGeneric 04/2017 - 01/2014
3	Oxygen (Dioxygen)IBA 04/2017 - 01/2014
3	Vascular Endothelial Growth Factor DIBA 12/2016 - 04/2013
2	LipopolysaccharidesIBA 01/2022 - 05/2006
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022 - 12/2016
2	OvalbuminIBA 01/2022 - 01/2019
2	Methacholine Chloride (Methacholine)FDA Link 01/2022 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 11/2019 - 09/2017
2	Histamine H1 Receptors (Histamine H1 Receptor)IBA 04/2019 - 02/2011
2	Histamine Antagonists (Antihistamines)IBA 04/2019 - 02/2011
2	PeriostinIBA 01/2019 - 04/2015
2	Protein D-Aspartate-L-Isoaspartate Methyltransferase (Protein L Isoaspartate D Aspartate O Methyltransferase)IBA 03/2018 - 04/2016
2	Isoaspartic Acid (Isoaspartate)IBA 03/2018 - 04/2016
2	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 09/2014 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2013 - 06/2009
2	OrexinsIBA 03/2005 - 07/2004
1	N-methylnaloxoneIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Opioid Receptors (Opioid Receptor)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Trace Elements (Biometals)IBA 11/2019
1	AllergensIBA 04/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	AlbuminsIBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 03/2018
1	D-Aspartic Acid (D Aspartate)IBA 03/2018
1	ThapsigarginIBA 03/2018
1	TransferasesIBA 03/2018
1	GlucocorticoidsIBA 03/2018
1	Tyrosine Kinase InhibitorsIBA 09/2017
1	AfatinibIBA 09/2017
1	Muscarinic AntagonistsIBA 04/2017
1	SteroidsIBA 04/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2016
1	gimeracilIBA 05/2016
1	Carcinoembryonic AntigenIBA 05/2016
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2016
1	Fluorouracil (Carac)FDA LinkGeneric 05/2016
1	TegafurIBA 05/2016
1	Indicators and Reagents (Reagents)IBA 05/2016
1	Oxonic AcidIBA 05/2016
1	PotassiumIBA 05/2016

Therapy/Procedure

7	Therapeutics 04/2019 - 12/2007
1	Bronchial Thermoplasty 04/2017
1	Ambulatory Care (Outpatient Care) 05/2016
1	Drug Therapy (Chemotherapy) 05/2016